Repare Therapeutics Inc (RPTX)
3.24
-0.04
(-1.22%)
USD |
NASDAQ |
Nov 14, 16:00
3.24
0.00 (0.00%)
After-Hours: 19:52
Repare Therapeutics Market Cap: 137.52M for Nov. 14, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2024 | 139.22M |
| November 12, 2024 | 148.35M |
| November 11, 2024 | 157.05M |
| November 08, 2024 | 152.38M |
| November 07, 2024 | 148.13M |
| November 06, 2024 | 153.23M |
| November 05, 2024 | 165.54M |
| November 04, 2024 | 151.95M |
| November 01, 2024 | 151.95M |
| October 31, 2024 | 142.19M |
| October 30, 2024 | 146.44M |
| October 29, 2024 | 152.38M |
| October 28, 2024 | 155.35M |
| October 25, 2024 | 147.71M |
| October 24, 2024 | 143.04M |
| October 23, 2024 | 145.59M |
| October 22, 2024 | 149.41M |
| October 21, 2024 | 152.80M |
| October 18, 2024 | 145.59M |
| October 17, 2024 | 142.19M |
| October 16, 2024 | 145.16M |
| October 15, 2024 | 142.62M |
| October 14, 2024 | 143.89M |
| October 11, 2024 | 133.28M |
| October 10, 2024 | 138.80M |
| Date | Value |
|---|---|
| October 09, 2024 | 140.49M |
| October 08, 2024 | 146.44M |
| October 07, 2024 | 146.44M |
| October 04, 2024 | 159.17M |
| October 03, 2024 | 146.86M |
| October 02, 2024 | 146.44M |
| October 01, 2024 | 147.29M |
| September 30, 2024 | 146.01M |
| September 27, 2024 | 146.01M |
| September 26, 2024 | 148.56M |
| September 25, 2024 | 143.47M |
| September 24, 2024 | 143.04M |
| September 23, 2024 | 143.47M |
| September 20, 2024 | 149.41M |
| September 19, 2024 | 148.56M |
| September 18, 2024 | 140.92M |
| September 17, 2024 | 139.65M |
| September 16, 2024 | 140.92M |
| September 13, 2024 | 149.83M |
| September 12, 2024 | 127.34M |
| September 11, 2024 | 119.27M |
| September 10, 2024 | 121.82M |
| September 09, 2024 | 120.55M |
| September 06, 2024 | 119.70M |
| September 05, 2024 | 116.73M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
116.73M
Minimum
Sep 05 2024
1.641B
Maximum
Jan 07 2021
643.37M
Average
543.65M
Median
Market Cap Benchmarks
| Aurinia Pharmaceuticals Inc | 1.192B |
| Edesa Biotech Inc | 7.079M |
| Lexaria Bioscience Corp | 33.36M |
| InMed Pharmaceuticals Inc | 66.97M |
| Xenon Pharmaceuticals Inc | 3.163B |
Market Cap Related Metrics
| PS Ratio | 2.013 |
| PEG Ratio | -0.0020 |
| Price to Book Value | 0.6752 |
| Price | 3.24 |
| Earnings Yield | -50.62% |
| PEGY Ratio | -0.0020 |